Aakash Desai, Associate Director, Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center, shared on X:
“PEARLS/KEYNOTE-091 final, ESMO26: adjuvant pembro, resected IB–IIIA NSCLC (n=1,177)
- DFS 58.7 vs 43.3 mo, HR 0.85
- OS HR 0.98 (0.81–1.18); 6-yr 68.5% vs 66.4%
- OS read time-triggered before planned deaths
Is DFS enough in adjuvant IO?”
You might be interested in:
